InsiderClue
Insiders · Profile

Shih Alvin

Director at ZEVRA THERAPEUTICS · EVP of Research & Development at Travere Therapeutics. Filing since 26 Jun 2015. CIK 0001610064

ZVRA ZEVRA THERAPEUTICS, INC. Director · 1 trade TVTX Travere Therapeutics, Inc. EVP of Research & Development · 6 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ZVRA ZEVRA THERAPEUTICS, INC.
12 Sep 2025
Director
Bought
20,000
$157.80K
opened
TVTX Travere Therapeutics, Inc.
1 Sep 2016
EVP of Research & Development
Sold, plan not stated
8,750
$142.06K
5.2%
TVTX Travere Therapeutics, Inc.
1 Jun 2016
EVP of Research & Development
Sold, plan not stated
8,750
$155.28K
5.0%
TVTX Travere Therapeutics, Inc.
1 Mar 2016
EVP of Research & Development
Sold, plan not stated
8,750
$125.57K
4.7%
TVTX Travere Therapeutics, Inc.
9 Dec 2015
EVP of Research & Development
Sold, plan not stated
8,750
$182.26K
4.5%
TVTX Travere Therapeutics, Inc.
6 Oct 2015
EVP of Research & Development
Sold, plan not stated
8,750
$176.07K
4.3%
TVTX Travere Therapeutics, Inc.
26 Jun 2015
EVP of Research & Development
Sold, plan not stated
27,916
$912.85K
12.1%
7 decisions on file.